Rapid On-line Profiling of Estrogen Receptor Binding Metabolites of Tamoxifen-Reference-Cited by-同舟云学术

Rapid On-line Profiling of Estrogen Receptor Binding Metabolites of Tamoxifen

Published:2006-05-06 Issue:11 Volume:49 Page:3287-3292
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kool Jeroen¹,Ramautar Rawi¹,van Liempd Sebastiaan M.¹,Beckman Joran¹,de Kanter Frans J. J.¹,Meerman John H. N.¹,Schenk Tim¹,Irth Hubertus¹,Commandeur Jan N. M.¹,Vermeulen Nico P. E.¹

Affiliation:

1. Leiden Amsterdam Center for Drug Research (LACDR)/Division of Molecular Toxicology, Department of Chemistry and Pharmacochemistry, Vrije Universiteit, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands, and Kiadis B.V., Zernikepark 6-8, 9747 AN Groningen, The Netherlands

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0507936

Reference29 articles.

1. Discovering Drugs through Biological Transformation: Role of Pharmacologically Active Metabolites in Drug Discovery

2. Reversed-Phase Liquid Chromatography Coupled On-Line to Receptor Affinity Detection Based on the Human Estrogen Receptor

3. Current Status of Adjuvant Therapy of Early Breast Cancer

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electron activated dissociation - a complementary fragmentation technique to collision-induced dissociation for metabolite identification of synthetic cathinone positional isomers;Analytica Chimica Acta;2023-12

2. In vitro metabolism of cathinone positional isomers: does sex matter?;Analytical and Bioanalytical Chemistry;2023-07-15

3. “Commandeuring” Xenobiotic Metabolism: Advances in Understanding Xenobiotic Metabolism;Chemical Research in Toxicology;2022-06-29

4. The Role of Biotransformation in the Activity of Endocrine Disruptors;Current Drug Metabolism;2021-07

5. Nanofractionation Platform with Parallel Mass Spectrometry for Identification of CYP1A2 Inhibitors in Metabolic Mixtures;SLAS DISCOVERY: Advancing the Science of Drug Discovery;2017-12-21